U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab
Hazarika, Maitreyee, Chuk, Meredith K, Theoret, Marc R, Mushti, Sirisha, He, Kun, Weis, Shawna L, Putman, Alexander H, Helms, Whitney S, Cao, Xianhua, Li, Hongshan, Zhao, Hong, Zhao, Liang, Welch, Joel, Graham, Laurie, Libeg, Meredith, Sridhara, Rajeshwari, Keegan, Patricia, Pazdur, Richard
Published in Clinical cancer research (15.07.2017)
Published in Clinical cancer research (15.07.2017)
Get full text
Journal Article
FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma
Chuk, Meredith K, Chang, Jennie T, Theoret, Marc R, Sampene, Emmanuel, He, Kun, Weis, Shawna L, Helms, Whitney S, Jin, Runyan, Li, Hongshan, Yu, Jingyu, Zhao, Hong, Zhao, Liang, Paciga, Mark, Schmiel, Deborah, Rawat, Rashmi, Keegan, Patricia, Pazdur, Richard
Published in Clinical cancer research (01.10.2017)
Published in Clinical cancer research (01.10.2017)
Get full text
Journal Article
Clinical pharmacology considerations for first-in-human clinical trials for enzyme replacement therapy
Stern, Sydney, Wang, Jie, Li, Ruo-Jing, Hon, Yuen Yi, Weis, Shawna L, Wang, Yow-Ming C, Schuck, Robert, Pacanowski, Michael
Published in Journal of inherited metabolic disease (13.05.2024)
Published in Journal of inherited metabolic disease (13.05.2024)
Get full text
Journal Article